These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 24759835

  • 21. MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.
    Chai ZT, Kong J, Zhu XD, Zhang YY, Lu L, Zhou JM, Wang LR, Zhang KZ, Zhang QB, Ao JY, Wang M, Wu WZ, Wang L, Tang ZY, Sun HC.
    PLoS One; 2013; 8(10):e77957. PubMed ID: 24194905
    [Abstract] [Full Text] [Related]

  • 22. Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma.
    Cardin R, Piciocchi M, Sinigaglia A, Lavezzo E, Bortolami M, Kotsafti A, Cillo U, Zanus G, Mescoli C, Rugge M, Farinati F.
    BMC Cancer; 2012 May 15; 12():177. PubMed ID: 22587342
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [MicroRNA profiling in patients with hepatocellular carcinoma].
    Wang CX, Song W, Li ZJ, Song B, Wu DH, Sun AM, Chen LH.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May 15; 30(5):976-7. PubMed ID: 20501372
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
    Xu Q, Cai W, Zhang M, Liu Q, Liu X.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar 15; 32(3):387-92. PubMed ID: 26927562
    [Abstract] [Full Text] [Related]

  • 29. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A, Fujita K, Iwama H, Chiyo T, Fujihara S, Oura K, Tadokoro T, Mimura S, Nomura T, Tani J, Yoneyama H, Kobayashi K, Kamada H, Guan Y, Nishiyama A, Okano K, Suzuki Y, Himoto T, Shimotohno K, Masaki T.
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar 01; 318(3):G401-G409. PubMed ID: 31905024
    [Abstract] [Full Text] [Related]

  • 30. Over-expression of MiR-122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4.
    Wei X, Liu H, Li X, Liu X.
    Ann Hepatol; 2019 Mar 01; 18(6):869-878. PubMed ID: 31477445
    [Abstract] [Full Text] [Related]

  • 31. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ, Lin Z, Chen XJ, Song M, Wang YQ, Cai YJ, Yang NB, Zheng MH, Dong JZ, Zhang L, Chen YP.
    Oncotarget; 2015 Sep 22; 6(28):25093-108. PubMed ID: 26231037
    [Abstract] [Full Text] [Related]

  • 32. miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature.
    Fittipaldi S, Vasuri F, Bonora S, Degiovanni A, Santandrea G, Cucchetti A, Gramantieri L, Bolondi L, D'Errico A.
    Dig Dis Sci; 2017 Sep 22; 62(9):2397-2407. PubMed ID: 28639131
    [Abstract] [Full Text] [Related]

  • 33. Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma.
    Zhang ZL, Liu ZS, Sun Q.
    World J Gastroenterol; 2006 Jul 14; 12(26):4241-5. PubMed ID: 16830384
    [Abstract] [Full Text] [Related]

  • 34. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma.
    Zhao X, Chen GQ, Cao GM.
    Eur Rev Med Pharmacol Sci; 2019 Aug 14; 23(16):6888-6898. PubMed ID: 31486488
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The microRNA-200 family--a potential diagnostic marker in hepatocellular carcinoma?
    Dhayat SA, Mardin WA, Köhler G, Bahde R, Vowinkel T, Wolters H, Senninger N, Haier J, Mees ST.
    J Surg Oncol; 2014 Sep 14; 110(4):430-8. PubMed ID: 24895326
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.